Skip to main content
. 2021 Apr 15;71(4):326–332. doi: 10.1016/j.bjane.2021.03.006

Table 2.

Substance usea by colleagues.

Respondents No personal history of substance use (n = 988) Personal history of substance use (n = 295) p-value
Known colleague substance use 1053 (82.07) 791 (80.06) 261 (88.78) 0.001
Number of colleagues known to use < 0.0001
 1–2 325 (30.89) 269 (34.05) 56 (21.46)
 3–5 477 (45.34) 357 (45.19) 119 (45.59)
 6–10 140 (13.31) 102 (12.91) 38 (14.56)
 > 10 110 (10.46) 62 (7.85) 48 (18.39)
Substances utilizedb
 Illicit stimulants 339 (32.38) 237 (30.19) 101 (38.70) 0.01
 Prescribed stimulants 382 (36.49) 222 (28.28) 160 (61.30) < 0.0001
 Anesthetic agents 401 (38.30) 311 (39.62) 89 (34.10) 0.11
 Opioids 702 (67.05) 576 (73.38) 125 (47.89) < 0.0001
 Marijuana 548 (52.34) 364 (46.37) 183 (70.11) < 0.0001
 Benzodiazepines 420 (40.11) 283 (36.05) 137 (52.49) < 0.0001
 Sleep induction/Maintenance medications 478 (45.65) 314 (40.00) 164 (62.84) < 0.0001
 Otherc 26 (2.48) 19 (2.42) 7 (2.68) 0.81
Time when use observed 0.001
 Both during and after residency 571 (54.64) 408 (52.04) 163 (62.45)
 During residency 196 (18.76) 144 (18.37) 52 (19.92)
 After residency 278 (26.60) 232 (29.59) 46 (17.62)
 Colleague withdrawn from professional activities due to substance use 737 (70.26) 595 (75.60) 142 (54.41) < 0.0001
Colleague returned to original professional activities 0.56
 Yes 282 (38.37) 234 (39.39) 48 (34.04)
 Yes, needed to withdraw later 274 (37.28) 221 (37.21) 53 (37.59)
 Did not return 92 (12.52) 71 (11.95) 21 (14.89)
 Unknown 87 (11.84) 68 (11.45) 19 (13.48)
 Respondent believed their colleague might have increased their occupational hazard 979 (93.15) 757 (95.94) 221 (84.67) < 0.0001
 Respondent believed their colleague might have jeopardized patient safety 923 (88.16) 723 (91.87) 199 (76.83) < 0.0001

Data is presented as n (%).

a

Note: Substance use is defined as ‘ever used or uses any substance with the potential of abuse to change mental status.

b

Respondents could select all that apply.

c

Other included alcohol, diethylpropion, crack, ecstasy, gamma-hydroxybutyrate, lysergic acid diethylamide, methamphetamine, fentanyl, toluene inhalation, lisdexamfetamine;